Michael T. Schweizer

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas et al. · Cancer Cell · 2017 · 733 citations · Full text

Urology, Hormonal Receptor, Fibroblast Growth Factor +4

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown et al. · Journal of Clinical Investigation · 2019 · 439 citations · Full text

Scnpc Pdx Models, Urology, Stratifies Diverse Phenotypes +15

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

Michael T. Schweizer, Emmanuel S. Antonarakis, Hao Wang et al. · Science Translational Medicine · 2015 · 250 citations · Full text

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

Daniel Nava Rodrigues, Pasquale Rescigno, David Liu et al. · Journal of Clinical Investigation · 2018 · 203 citations · Full text

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

Benjamin A. Teply, Hao Wang, Brandon Luber et al. · The Lancet Oncology · 2017 · 192 citations · Full text

Bipolar Androgen Therapy, Urology, Oncology +7